Not available
Quote | Intec Pharma Ltd. (NASDAQ:NTEC)
Last: | $9.63 |
---|---|
Change Percent: | -12.48% |
Open: | $11 |
Close: | $9.63 |
High: | $11.0973 |
Low: | $9.59 |
Volume: | 980,394 |
Last Trade Date Time: | 08/03/2021 04:42:34 am |
News | Intec Pharma Ltd. (NASDAQ:NTEC)
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural killer cells, dendritic cells, Th1 CD4, and CD8 T cells NEW YORK, March 25, 2024 (...
Message Board Posts | Intec Pharma Ltd. (NASDAQ:NTEC)
Subject | By | Source | When |
---|---|---|---|
znewcar1: NTEC 48% v34M c13.55 f1,842M Was f3.9M about half and Price doubled. | znewcar1 | investorshangout | 07/29/2021 8:27:57 PM |
whytestocks: $NTEC News Article - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers | whytestocks | investorshangout | 05/11/2021 12:05:48 PM |
znewcar1: NTEC 29% v15M c5.96 f3,9M preMH13.7 OH7.49 S5.60 | znewcar1 | investorshangout | 03/15/2021 8:40:57 PM |
znewcar1: NTEC 34% v29,2M c4.64 f3,9M preMH8.7 HOD7.12 then flushed | znewcar1 | investorshangout | 12/09/2020 9:57:54 PM |
whytestocks: $NTEC News Article - Intec Pharma to Present at Oppenheimer Fall Healthcare Life Scienc | whytestocks | investorshangout | 09/14/2020 8:36:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Intec Pharma Ltd. Company Name:
NTEC Stock Symbol:
NASDAQ Market:
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
Data demonstrates that Company’s Decoy platform successfully induces or activates multiple immune cell types involved in anti-tumor responses New data shows activity in M1 macrophages, natural killer cells, dendritic cells, Th1 CD4, and CD8 T cells NEW YORK, March 25, 2024 (...
“Fully Engaging The Human Immune System To Cure Disease,” Featuring CEO, Jeffrey Meckler Registration now open at INDPMarch2024.TribePublic.com NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ: INDP), a clinical stage biotech...